beta

VKTX

Viking Therapeutics, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Market Cap: 554 Million

Primary Exchange: NASDAQ

Website: http://www.vikingtherapeutics.com

Shares Outstanding: 72.8 Million

Float: 70.9 Million

Dividend: (%)

Beta: 1.13123073766086

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 765 trading days

From: 2015-05-06 To: 2018-05-30

Lowest Point:

MT, ZYNE among premarket gainers

via: SeekingAlpha at 2019-06-11 05:21:22:000

Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...

MT, ZYNE among premarket gainers

via: SeekingAlpha at 2019-06-11 05:21:22:000

Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...

MT, ZYNE among premarket gainers

via: SeekingAlpha at 2019-06-11 05:21:22:000

Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...

A Closer Look: Genfit's Prospects In NASH

via: SeekingAlpha at 2019-06-10 08:26:04:000

Introduction Much has been made of the NASH race, which came to a pinnacle of hype in 2018 with stocks like Madrigal ( MDGL ) & Viking ( VKTX ) quadrupling in value. The mood has since subdued, as the realization of competition and the hurdles to market have set in. Genfit ( OTCPK:GNF… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud